Treeline Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate TLN-121 in Combination with CD20xCD3 T-Cell-Engaging Bispecific Antibodies

Roche partnership validates TLN-121 with CD20xCD3 bispecifics, boosting corporate credibility.